Carbamazepine inhibits L-type Ca2+ channels in cultured rat hippocampal neurons stimulated with glutamate receptor agonists

Neuropharmacology

Volumn 38, Issue 9, 1999, Pages 1349-1359

  Ambrósio, António F ^a   Silva, Ana P ^a   Malva, João O ^a,b   Soares Da Silva, Patrício ^c   Carvalho, Arsélio P ^a   Carvalho, Caetana M ^a  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b UNIVERSITY OF COIMBRA   (Portugal)

^c NONE

Author keywords

Ca2+ (i); Na+ (i); Carbamazepine; Glutamate ionotropic receptors; Kainate; Voltage sensitive Ca2+ channels; Voltage sensitive Na+ channels

Indexed keywords

1 (4 AMINOPHENYL) 3,4 DIHYDRO 4 METHYL 3 METHYLCARBAMOYL 7,8 METHYLENEDIOXY 5H 2,3 BENZODIAZEPINE; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; CARBAMAZEPINE; DIZOCILPINE; GLUTAMATE RECEPTOR AGONIST; GLUTAMIC ACID; IONOTROPIC RECEPTOR; KAINIC ACID; N METHYL DEXTRO ASPARTIC ACID; NITRENDIPINE; OMEGA CONOTOXIN GVIA; TETRODOTOXIN; UNCLASSIFIED DRUG; VERATRIDINE;

ANIMAL TISSUE; ARTICLE; CALCIUM TRANSPORT; CONTROLLED STUDY; EMBRYO; FLUORESCENCE; HIPPOCAMPUS; NERVE CELL CULTURE; NONHUMAN; PRIORITY JOURNAL; RAT; SODIUM TRANSPORT;

ANIMALS; ANTICONVULSANTS; CALCIUM; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS, L-TYPE; CARBAMAZEPINE; CELLS, CULTURED; EXCITATORY AMINO ACID AGONISTS; HIPPOCAMPUS; KAINIC ACID; NEURONS; RATS; RATS, WISTAR; RECEPTORS, GLUTAMATE; SODIUM;

EID: 18244425608     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(99)00058-1     Document Type: Article

References (52)

1. i signals stimulated by ionotropic glutamate receptor agonists. Eur. J. Neurosci. 10(10):1998;48-54.
2. 2+ channels in rat hippocampal nerve terminals by the adenosine A1 receptor. Eur. J. Pharmacol. 340:1997;301-310.
3. Ben-Ari Y. Limbic seizures and brain damage produced by kainic acid: mechanisms and relevance to human temporal lobe epilepsy. Neuroscience. 14:1985;375-403.
4. Berridge M.J. Neuronal calcium signaling. Neuron. 21:1998;13-26.
5. Biber K., Walden J., Gebickeharter P., Berger M., Vancalker D. Carbamazepine inhibits the potentiation by adenosine-analogs of agonist-induced inositolphosphate formation in hippocampal astrocyte cultures. Biol. Psychiatry. 40:1996;563-567.
6. Brewer G.J., Torricelli J.R., Evege E.K., Price P.J. Optimized survival of hippocampal neurons in B27-supplemented Neurobasal TM, a new serum-free medium combination. J. Neurosci. Res. 35:1993;567-576.
7. 2+ levels in neuronal culture. Eur. J. Pharmacol. 219:1992;53-57.
8. Chen G., Pan B.S., Hawver D.B., Wright C.B., Potter W.Z. Attenuation of cyclic-AMP production by carbamazepine. J.Neurochem. 67:1996;2079-2086.
9. Courtney M.J., Lambert J.J., Nicholls D.G. The interactions between plasma membrane depolarization and glutamate receptor activation in the regulation of cytoplasmic free calcium in cultured cerebellar granule cells. J. Neurosci. 10:1990;3873-3879.
10. Croucher M.J., Collins J.F., Meldrum B.S. Anticonvulsant action of excitatory amino acid antagonists. Science. 216:1982;899-901.
11. 2+. Eur. J. Pharmacol. 328:1997;153-162.
12. Dailey J.W., Reith M.E.A., Yan Q.S., Li M.Y., Jobe P.C. Anticonvulsant doses of carbamazepine increase hippocampal extracellular serotonin in genetically epilepsy-prone rats-dose response relationships. Neurosci. Lett. 227:1997;13-16.
13. Elliott P. Action of antiepileptic and anaesthetic drugs on Na- and Ca-spikes in mammalian non-myelinated axons. Eur. J. Pharmacol. 175:1990;155-163.
14. Gean P.W., Huang C.C., Kuo J.R., Lin J.H., Yi P.L., Tsai J.J. Analysis of carbamazepine's anticonvulsant actions in hippocampal and amygdaloid slices of the rat. Chin. J. Physiol. 36:1993;199-204.
15. 2+ permeability are not mediated by voltage-gated potassium channels. J. Biol. Chem. 261:1986;11520-11523.
16. Grant K.A., Snell L.D., Rogawski M.A., Thurkauf A., Tabakoff B. Comparison of the effects of the uncompetitive N-methyl-D-aspartate antagonist (±)-5-aminocarbonyl-10,11-dihydro-5H-dibenzo [a,d] cyclohepten-5,10-imine (ADCI) with its structural analogue dizocilpine (MK-801) and carbamazepine on ethanol withdrawal seizures. J. Pharmacol. Exp. Ther. 260:1992;1017-1022.
17. Hough C.J., Irwin R.P., Gao X.-M., Rogawski M.A., Chuang D.-M. Carbamazepine inhibition of N-methyl-D-aspartate-evoked calcium influx in rat cerebellar granule cells. J. Pharmacol. Exp. Ther. 276:1996;143-149.
18. Kapetanovic I.M., Yonekawa W.D., Kupferberg H.J. The effects of anticonvulsant compounds on 4-aminopyridine-induced de novo synthesis of neurotransmitter aminoacids in rat hippocampus in vitro. Epilepsy Res. 20:1995;113-120.
19. Keith R.A., Mangano T.J., Salama A.I. Inhibition of N-methyl-D-aspartate- and kainic acid-induced neurotransmitter release by omega-conotoxin GVIA. Br. J. Pharmacol. 98:1989;767-772.
20. + currents-quantitative distinction from phenytoin and possible therapeutic implications. Mol. Pharmacol. 51:1997;1077-1083.
21. Lakics V., Molnar P., Erdo S.L. Protection against veratridine toxicity in rat cortical cultures - relationship to sodium-channel blockade. NeuroReport. 7:1995;89-92.
22. Lampe H., Bigalpe H. Carbamazepine blocks NMDA-activated currents in cultured spinal cord neurons. NeuroReport. 1:1990;26-28.
23. Lancaster J.M., Davies J.A. Carbamazepine inhibits NMDA-induced depolarization in cortical wedges prepared from DBA/2 mice. Experientia. 48:1992;751-753.
24. Löscher W. Pharmacology of glutamate receptor antagonists in the kindling model of epilepsy. Prog. Neurobiol. 54:1998;721-741.
25. 2+ influx underlies potent induction of injury. J. Neurosci. 16:1996;5457-5465.
26. MacDonald R.L., Kelly K.M. Antiepileptic drug mechanisms of action. Epilepsia. 34(5):1993;51-58.
27. Malva J.O., Ambrósio A.F., Carvalho A.P., Carvalho C.M. AMPA and kainate receptors are active in different regions of the cell membrane in hippocampal neurons. Eur. J. Neurosci. 10(10):1998;37-54.
28. Malva J.O., Carvalho A.P., Carvalho C.M. Domoic acid induces the release of glutamate in the rat hippocampal CA3 sub-region. NeuroReport. 7:1996;1330-1334.
29. 2+ deregulation and cytoskeletal pathology. Neurobiol. Aging. 16:1995;187-198.
30. Minato H., Kikuta C., Fujitani B., Masuda Y. Protective effect of zonisamide, an antiepileptic drug, against focal cerebral ischemia with middle cerebral artery occlusion-reperfusion in rats. Epilepsia. 38:1997;975-980.
31. Morimoto K., Sato H., Sato K., Sato S., Yamada N. BW 1003C87, phenytoin and carbamazepine elevate seizure threshold in the rat amygdala-kindling model of epilepsy. Eur. J. Pharmacol. 339:1997;11-15.
32. 2+ influx into striatal neurons by kainic acid. J. Pharmacol. Exp. Ther. 249:1989;184-193.
33. +, carbamazepine and zonizamide on hippocampal extracellular glutamate monitored with a microdialysis electrode. Br. J. Pharmacol. 124:1998;1277-1285.
34. Olpe H., Kolb C.N., Hausdorf A., Haas H.L. 4-aminopyridine and barium chloride attenuate the antiepileptic effect of carbamazepine in hippocampal slices. Experientia. 47:1991;254-257.
35. Olpe H.-R., Baudry M., Jones R.S.G. Electrophysiological and neurochemical investigations on the action of carbamazepine on the rat hippocampus. Eur. J. Pharmacol. 110:1985;71-80.
36. 2+through glutamate receptor channels. Semin. Neurosci. 8:1996;261-269.
37. Phillips I., Martin K.F., Thompson K.S.J., Heal D.J. Weak blockade of AMPA receptor-mediated depolarizations in the rat cortical wedge by phenytoin but not lamotrigine or carbamazepine. Eur. J. Pharmacol. 337:1997;189-195.
38. Rogawski M.A. Excitatory amino acids and seizures. Stone T.W. CNS Neurotransmitters and Neuromodulators-Glutamate. 1995;219-237 CRC, London. Chp. 13.
39. Rogawski M.A., Porter R.J. Antiepileptic drugs: pharmacological mechanisms and clinical efficacy with consideration of promising developmental stage compounds. Pharmacol. Rev. 42:1990;223-286.
40. Rush A.M., Elliott J.R. Phenytoin and carbamazepine - differential inhibition of sodium currents in small cells from adult rat dorsal root ganglia. Neurosci. Lett. 226:1997;95-98.
41. Sayer R.J., Brown A.M., Schwindt P.C., Crill W.E. Calcium currents in acutely isolated human neocortical neurons. J. Neurophysiol. 69:1993;1596-1606.
42. Schirrmacher K., Mayer A., Walden J., Dusing R., Bingmann D. Effects of carbamazepine on action potentials and calcium currents in rat spinal ganglion cells in vitro. Neuropsychobiology. 27:1993;176-179.
43. Schirrmacher K., Mayer A., Walden J., Dusing R., Bingmann D. Effects of carbamazepine on membrane properties of rat sensory spinal ganglion cells in vitro. Eur. Neuropsychopharmacol. 5:1995;501-507.
44. + channel in rat dorsal root ganglion neurons and their blockade by halothane. Eur. J. Neurosci. 10:1998;2547-2556.
45. Schumacher T.B., Beck H., Steinhäuser C., Schramm J., Elger C.E. Effects of phenytoin, carbamazepine, and gabapentin on calcium channels in hippocampal granule cells from patients with temporal lobe epilepsy. Epilepsia. 39:1998;355-363.
46. Sofia R.D., Gordon R., Gels M., Diamantis W. Comparative effects of felbamate and other compounds on N-methyl-D-aspartic acid-induced convulsions and lethality in mice. Pharmacol. Res. 29:1994;139-144.
47. Turski L., Meldrum B.S., Turski W.A., Watkins J.C. Evidence that antagonism at non-NMDA receptors results in anticonvulsant action. Eur. J. Pharmacol. 136:1987;69-73.
48. Vonwegerer J., Hesslinger B., Berger M., Walden J. A calcium antagonistic effect of the new antiepileptic drug lamotrigine. Eur. Neuropsychoparmacol. 7:1997;77-81.
49. Waldmeier P.C., Martin P., Stocklin K., Portet C., Schmutz M. Effect of carbamazepine, oxcarbazepine and lamotrigine on the increase in extracellular glutamate elicited by veratridine in rat cortex and striatum. Naunyn Schmiedeberg Arch. Pharmacol. 354:1996;164-172.
50. 1 subunit. J. Neurosci. 15:1995;6419-6432.
51. Yoshida S. Tetrodotoxin-resistant sodium channels. Cell. Mol. Neurobiol. 14:1994;227-244.
52. Yoshimura R., Yanagihara N., Terao T., Minami K., Toyohira Y., Ueno S., Uezono Y., Abe K., Izumi F. An active metabolite of carbamazepine, carbamazepine-10,11-epoxide, inhibits ion channel-mediated catecholamine secretion in cultured bovine adrenal medullary cells. Psychopharmacology. 135:1998;368-373.